Lfcr investors have opportunity to lead lifecore biomedical, inc. securities fraud lawsuit

Los angeles , sept. 13, 2024 /prnewswire/ -- glancy prongay & murray llp ("gpm") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against lifecore biomedical, inc. ("lifecore" or the "company") (nasdaq: lfcr).

LFCR Ratings Summary

LFCR Quant Ranking